4.1 Review

The Prevalence of Metabolic Syndrome In Chronic Obstructive Pulmonary Disease: A Systematic Review

Journal

Publisher

TAYLOR & FRANCIS INC
DOI: 10.3109/15412555.2016.1140732

Keywords

Co-morbidities; components; lifestyle; prevalence

Funding

  1. Lung Foundation Netherlands [3.4.12.023]

Ask authors/readers for more resources

Type 2 Diabetes Mellitus (T2DM) and cardiovascular diseases (CVD) are common in patients with chronic obstructive pulmonary disease (COPD). Prevention of these co-morbidities in COPD requires knowledge on their risk factors. Metabolic syndrome (MetS) predisposes to the development of T2DM and CVD but its prevalence in COPD remains unclear. The aim of this review was to assess the prevalence of MetS and its components in COPD patients compared to controls and to investigate the contribution of clinical characteristics to MetS prevalence. We systematically searched PubMed and EMBASE for original studies in COPD that have investigated the prevalence of MetS and its components. In total, 19 studies involving 4208 COPD patients were included. The pooled MetS prevalence was 34%. Compared to controls, the prevalence was higher in COPD (10 studies, 32% and 30%, p = 0.001). The three most prevalent components in both COPD and controls were arterial hypertension (56% and 51%), abdominal obesity (39% and 38%) and hyperglycemia (44% and 47%). Compared to COPD patients without MetS, those with MetS had higher body mass index (BMI) (29.9 and 24.6 kg/m(2), p < 0.001), higher forced expiratory volume in 1 second (FEV1) % predicted (54 and 51, p < 0.001) and were more frequently female (31% and 25%, p = 0.011). In conclusion, the prevalence of MetS in COPD patients is high and hypertension, abdominal obesity and hyperglycemia are the most prevalent components. Further studies are needed to evaluate the impact of lifestyle factors and medications on MetS in COPD.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.1
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Review Clinical Neurology

Efficacy and safety of vitamin-K antagonists and direct oral anticoagulants for stroke prevention in patients with heart failure and sinus rhythm: An updated systematic review and meta-analysis of randomized clinical trials

Weijia Li, Jiyoung Seo, Damianos G. Kokkinidis, Leonidas Palaiodimos, Sanjana Nagraj, Eleni Korompoki, Haralambos Milionis, Wolfram Doehner, Gregory Y. H. Lip, George Ntaios

Summary: The use of oral anticoagulation therapy in patients with heart failure and sinus rhythm can reduce the occurrence of stroke, but it also increases the risk of major bleeding. Rivaroxaban has a better effect in preventing stroke, but it is also associated with a higher risk of bleeding. There were no significant differences between the use of oral anticoagulants and the control group in terms of myocardial infarction, all-cause mortality, and hospitalization for heart failure.

INTERNATIONAL JOURNAL OF STROKE (2023)

Article Cardiac & Cardiovascular Systems

Weight change and clinical outcomes in heart failure with reduced ejection fraction: insights from EMPEROR-Reduced

Stefan D. Anker, Muhammad Shahzeb Khan, Javed Butler, Anne Pernille Ofstad, Barbara Peil, Egon Pfarr, Wolfram Doehner, Naveed Sattar, Andrew J. S. Coats, Gerasimos Filippatos, Joao Pedro Ferreira, Faiez Zannad, Stuart Pocock, Milton Packer

Summary: In this study, the relationship between baseline BMI, weight loss, and the effects of empagliflozin on heart failure patients with reduced ejection fraction (HFrEF) were analyzed. The study found that the benefits of empagliflozin were consistent across all BMI categories, and weight loss was associated with increased risk of all-cause mortality regardless of treatment group.

EUROPEAN JOURNAL OF HEART FAILURE (2023)

Article Cardiac & Cardiovascular Systems

How to optimize the adherence to a guideline-directed medical therapy in the secondary prevention of cardiovascular diseases: a clinical consensus statement from the European Association of Preventive Cardiology

Roberto F. E. Pedretti, Dominique Hansen, Marco Ambrosetti, Maria Back, Thomas Berger, Mariana Cordeiro Ferreira, Veronique Cornelissen, Constantinos H. Davos, Wolfram Doehner, Carmen de Pablo Y. Zarzosa, Ines Frederix, Andrea Greco, Donata Kurpas, Matthias Michal, Elena Osto, Susanne Pedersen, Rita Esmeralda Salvador, Maria Simonenko, Patrizia Steca, David R. Thompson, Matthias Wilhelm, Ana Abreu

Summary: Optimal patient adherence to treatment is crucial for successful secondary prevention of cardiovascular disease (CVD). However, unsatisfactory adherence rates have been consistently observed for CVD risk factors and treatment. This consensus document provides a modern reappraisal of adherence to optimal treatment and offers simple, practical, and feasible suggestions to achieve this goal in the clinical setting, focusing on evidence-based concepts.

EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2023)

Review Cardiac & Cardiovascular Systems

Systematic review and meta-analysis of intravenous iron-carbohydrate complexes in HFrEF patients with iron deficiency

Andrew Sindone, Wolfram Doehner, Josep Comin-Colet

Summary: Intravenous iron-carbohydrate complex supplementation has a positive effect on heart failure patients, reducing hospitalization rates and improving functional and exercise capacity.

ESC HEART FAILURE (2023)

Article Cardiac & Cardiovascular Systems

Comparison of Investigator-Reported and Centrally Adjudicated Heart Failure Outcomes in the EMPEROR-Reduced Trial

Peter Carson, John R. Teerlink, Michel Komajda, Inder Anand, Stefan D. Anker, Javed Butler, Wolfram Doehner, Joao Pedro Ferreira, Gerasimos Filippatos, Markus Haass, Alan Miller, Steen Pehrson, Stuart J. Pocock, Sven Schnaidt, Janet M. Schnee, Faiez Zannad, Milton Packer

Summary: There is limited published information on outcome adjudication in heart failure (HF). In this study, the authors compared investigator reports (IRs) to a Clinical Events Committee (CEC) and found that IRs can be an alternative to CEC with similar accuracy and faster event accumulation. They also suggest broadening the definition of hospitalization for heart failure (HHF) to include for or with worsening disease.

JACC-HEART FAILURE (2023)

Article Cardiac & Cardiovascular Systems

The DZHK research platform: maximisation of scientific value by enabling access to health data and biological samples collected in cardiovascular clinical studies

Julia Hoffmann, Sabine Hanss, Monika Kraus, Jens Schaller, Christian Schaefer, Dana Stahl, Stefan D. Anker, Gabriele Anton, Thomas Bahls, Stefan Blankenberg, Arne Blumentritt, Leif-Hendrik Boldt, Steffen Cordes, Steffen Desch, Wolfram Doehner, Marcus Doerr, Frank Edelmann, Ingo Eitel, Matthias Endres, Stefan Engelhardt, Jeanette Erdmann, Katharina Eulenburg, Volkmar Falk, Stephan B. Felix, Derk Frank, Thomas Franke, Norbert Frey, Tim Friede, Lars Geidel, Lisa Germans, Ulrich Grabmaier, Martin Halle, Joerg Hausleiter, Vera Jakobi, Ahmad-Fawad Jebran, Alexander Jobs, Stefan Kaeaeb, Mahir Karakas, Hugo A. Katus, Alexandra Klatt, Christoph Knosalla, Joachim Krebser, Ulf Landmesser, Mahsa Lee, Kristin Lehnert, Stephanie Lesser, Katrin Leyh, Roberto Lorbeer, Stephanie Mach-Kolb, Benjamin Meder, Eike Nagel, Christian H. Nolte, Abdul S. Parwani, Astrid Petersmann, Miriam Puls, Henriette Rau, Maximilian Reiser, Otto Rienhoff, Tabea Scharfe, Mario Schattschneider, Heiko Scheel, Renate B. Schnabel, Andreas Schuster, Boris Schmitt, Tim Seidler, Moritz Seiffert, Barbara-Elisabeth Staehli, Adriane Stas, Thomas J. Stocker, Lukas von Stuelpnagel, Holger Thiele, Rolf Wachter, Reza Wakili, Tanja Weis, Kerstin Weitmann, Heinz-Erich Wichmann, Philipp Wild, Tanja Zeller, Wolfgang Hoffmann, Elisabeth Maria Zeisberg, Wolfram-Hubertus Zimmermann, Dagmar Krefting, Titus Kuehne, Annette Peters, Gerd Hasenfuss, Steffen Massberg, Thomas Sommer, Stefanie Dimmeler, Thomas Eschenhagen, Matthias Nauck

Summary: The German Centre for Cardiovascular Research (DZHK) aims to conduct early and guideline-relevant studies to develop new therapies and diagnostics for people with cardiovascular disease. The DZHK designed a research platform to standardize data and sample collections across all studies and ensure compliance with legal regulations and FAIR principles. The platform includes web-based and central units for data management, as well as a Public Open Data strategy to enable interdisciplinary use of data and samples.

CLINICAL RESEARCH IN CARDIOLOGY (2023)

Article Cardiac & Cardiovascular Systems

The small molecule ACM-001 improves cardiac function in a rat model of severe cancer cachexia

Mareike S. Poetsch, Sandra Palus, Sophie Van Linthout, Stephan von Haehling, Wolfram Doehner, Andrew J. S. Coats, Stefan D. Anker, Jochen Springer

Summary: This study compared the effects of different doses of ACM-001 and other cardiac drugs on cardiac mass and function in tumor-induced cachexia rats. The results showed that 3 mg/kg/day ACM-001 reduced weight loss and attenuated lean mass wasting, while improving cardiac function.

EUROPEAN JOURNAL OF HEART FAILURE (2023)

Article Cardiac & Cardiovascular Systems

Bone status in men with heart failure: results from the Studies Investigating Co-morbidities Aggravating Heart Failure

Goran Loncar, Tania Garfias-Veitl, Miroslava Valentova, Mirela Vatic, Mitja Lainscak, Danilo Obradovic, Thomas Bernd Dschietzig, Wolfram Doehner, Ewa A. Jankowska, Stefan D. Anker, Stephan von Haehling

Summary: The aim of this study was to assess hip bone mineral density (BMD) in men with heart failure (HF). Dual energy X-ray absorptiometry was used to measure BMD in 141 male patients with HF. Patients with lower BMD were older, more likely to have sarcopenia, and had lower peak oxygen consumption compared to patients with higher BMD. Serum osteocalcin remained independently related to lower BMD in multivariate logistic regression analysis. Hip BMD and serum osteoprotegerin were independent predictors of impaired survival.

EUROPEAN JOURNAL OF HEART FAILURE (2023)

Letter Respiratory System

Chronic thromboembolic pulmonary hypertension and clot resolution after COVID-19-associated pulmonary embolism

Cindy M. M. de Jong, Chantal Visser, Remy H. H. Bemelmans, Wim G. Boersma, Bram van den Borst, J. Louise I. Burggraaf, Suzanne C. Cannegieter, Arina J. ten Cate-Hoek, F. Nanne Croles, Harald J. Faber, Laura M. Faber, Merel E. Hellemons, Lisa M. Hessels, Menno Huisman, Pieter W. Kamphuisen, Stephanie C. E. Koster, Lucia J. M. Kroft, Ivo van der Lee, Jenneke Leentjens, Karina Meijer, Maarten K. Ninaber, Brigitte M. Sondermeijer, Susanne Stads, Anton Vonk Noordegraaf, Kristien Winckers, Marieke J. H. A. Kruip, Frederikus A. Klok

EUROPEAN RESPIRATORY JOURNAL (2023)

Article Multidisciplinary Sciences

Plasma bioactive adrenomedullin predicts outcome after acute stroke in early rehabilitation

Azadeh Shafieesabet, Nadja Jauert, Oliver Hartmann, Birte Arlt, Michael Joebges, Wolfram Doehner

Summary: The aim of this study was to investigate the prognostic value of bioactive adrenomedullin (bio-ADM) on outcomes after rehabilitation in stroke patients. The results showed that plasma bio-ADM levels were associated with 6-month all-cause mortality and composite outcomes. Elevated bio-ADM concentrations (> 70 pg/ml) were associated with higher rates of all-cause mortality and composite outcomes. Therefore, bio-ADM may be a suitable novel biomarker to assess the outcomes of patients in rehabilitation after acute stroke.

SCIENTIFIC REPORTS (2023)

Article Clinical Neurology

Enhanced diagnostic workup increases pathological findings in patients with acute ischaemic stroke: results of the prospective HEBRAS study

Simon Hellwig, Thomas Krause, Jan F. Scheitz, Juliane Herm, Ulrike Grittner, Nadja Jauert, Jochen B. Fiebach, Mario Kasner, Wolfram Doehner, Matthias Endres, Rolf Wachter, Thomas Elgeti, Christian H. Nolte, Karl Georg Haeusler

Summary: This study compared the rate of pathological findings in patients with acute ischemic stroke (AIS) between enhanced diagnostic workup and routine diagnostic care. The results showed that enhanced diagnostic workup yielded a higher rate of pathological findings and reduced the proportion of patients with cryptogenic stroke.

STROKE AND VASCULAR NEUROLOGY (2023)

Article Cardiac & Cardiovascular Systems

Magnetic resonance imaging of organ iron before and after correction of iron deficiency in patients with heart failure

Christoph Gertler, Nadja Jauert, Patrick Freyhardt, Miroslava Valentova, Sven Christopher Aland, Thula Cannon Walter-Rittel, Christina Unterberg-Buchwald, Marius Placzek, Virginia Ding-Reinelt, Tarek Bekfani, Wolfram Doehner, Gerd Hasenfuss, Bernd Hamm, Anja Sandek

Summary: This study analyzed the changes in iron signal and exercise capacity in chronic heart failure patients before and after intravenous iron therapy. The findings showed that patients with iron deficiency had lower iron content in the spleen, liver, and heart. After intravenous iron therapy, the iron content in the left ventricle, spleen, and liver increased. Improvement in exercise capacity was associated with an increase in hemoglobin levels after intravenous iron therapy.

ESC HEART FAILURE (2023)

Review Cardiac & Cardiovascular Systems

Poststroke Cardiovascular Management: Current Concepts, Integrated Care, and Future Developments

Gregory Y. H. Lip, Radoslaw Lenarczyk, Daniele Pastori, George Ntaios, Wolfram Doehner, Renate B. Schnabel

Summary: After an ischemic stroke, patients often experience cardiovascular complications known as stroke-heart syndrome. Managing these cardiovascular issues is crucial for life expectancy and quality of life, and requires a multidisciplinary approach involving healthcare professionals. Integrated care is key to improving outcomes for patients with stroke-heart syndrome, involving appropriate antithrombotic therapy, assessment of poststroke impairments, and management of cardiovascular risk factors and comorbidities.

CURRENT PROBLEMS IN CARDIOLOGY (2023)

Review Medicine, General & Internal

Heart failure and the heart-brain axis

Wolfram Doehner, Jelena Celutkiene, Mehmet Birhan Yilmaz, Andrew J. S. Coats

Summary: Heart failure (HF) can lead to cerebral injury, such as stroke, cognitive decline, dementia, and depressive disorders. The interaction between the heart and the central nervous system (CNS) is significant, with impaired cerebral functions contributing to myocardial injury and worsening of HF symptoms. However, this comorbidity is often overlooked in both diagnosis and treatment of HF. This article discusses the pathophysiological aspects of heart-CNS interactions in HF, including stroke, cognitive function, depressive disorder, and neurovegetative control.

QJM-AN INTERNATIONAL JOURNAL OF MEDICINE (2023)

Article Medicine, General & Internal

The polypill in cardiovascular prevention: successful through simplification? New study results on the benefit of the polypill strategy in primary and secondary prevention

Patrick Despang, Martin Schikora, Wolfram Doehner

Summary: Cardiovascular disease is a major cause of death globally, with high blood pressure and elevated LDL cholesterol being major modifiable risk factors. The polypill, a combination of different drugs in one tablet, has been shown to significantly improve patients' prognosis by reducing cardiovascular events. While previous trials have focused on risk factor control, recent trials have shown prognostic improvement in primary prevention and the SECURE trial has shown a reduction in cardiovascular events in secondary prevention.

INNERE MEDIZIN (2023)

No Data Available